Consistently with these literature reports, we found that IGF2BP1 affects expression of EZH2 and its downstream effectors regulating cell proliferation, such as CDK2 and CCNE1 in neuroendocrine tumor cells, thereby driving G1/S transition. The gene discussed is CDK2; the disease is neuroendocrine neoplasm.